These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 647681

  • 1. Evidence that benzo(a)anthracene 3,4-diol-1,2-epoxide is an ultimate carcinogen on mouse skin.
    Levin W, Thakker DR, Wood AW, Chang RL, Lehr RE, Jerina DM, Conney AH.
    Cancer Res; 1978 Jun; 38(6):1705-10. PubMed ID: 647681
    [No Abstract] [Full Text] [Related]

  • 2. Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin.
    Slaga TJ, Gleason GL, DiGiovanni J, Sukumaran KB, Harvey RG.
    Cancer Res; 1979 Jun; 39(6 Pt 1):1934-6. PubMed ID: 109189
    [Abstract] [Full Text] [Related]

  • 3. High stereoselectivity among the optical isomers of the diastereomeric bay-region diol-epoxides of benz(a)anthracene in the expression of tumorigenic activity in murine tumor models.
    Levin W, Chang RL, Wood AW, Yagi H, Thakker DR, Jerina DM, Conney AH.
    Cancer Res; 1984 Mar; 44(3):929-33. PubMed ID: 6692415
    [Abstract] [Full Text] [Related]

  • 4. Tumorigenicity of the dihydrodiols of dibenzo(a,h)anthracene on mouse skin and in newborn mice.
    Buening MK, Levin W, Wood AW, Chang RL, Yagi H, Karle JM, Jerina DM, Conney AH.
    Cancer Res; 1979 Apr; 39(4):1310-4. PubMed ID: 421214
    [No Abstract] [Full Text] [Related]

  • 5. Mouse skin tumor-initiating activity of 5-, 7-, and 12-methyl- and fluorine-substituted benz[a]anthracenes.
    Wood AW, Levin W, Chang RL, Conney AH, Slaga TJ, O'Malley RF, Newman MS, Buhler DR, Jerina DM.
    J Natl Cancer Inst; 1982 Sep; 69(3):725-8. PubMed ID: 6810009
    [Abstract] [Full Text] [Related]

  • 6. Carcinogenicity and mutagenicity of benz(a)anthracene diols and diol-epoxides.
    Slaga TJ, Huberman E, Selkirk JK, Harvey RG, Bracken WM.
    Cancer Res; 1978 Jun; 38(6):1699-704. PubMed ID: 647680
    [Abstract] [Full Text] [Related]

  • 7. Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo(a)pyrene 7,8-diol-9,10-epoxides.
    Slaga TJ, Bracken WJ, Gleason G, Levin W, Yagi H, Jerina DM, Conney AH.
    Cancer Res; 1979 Jan; 39(1):67-71. PubMed ID: 761200
    [No Abstract] [Full Text] [Related]

  • 8. Mutagenicity and tumor-initiating activity of fluorinated derivatives of 7,12-dimethylbenz(a)anthracene.
    Huberman E, Slaga TJ.
    Cancer Res; 1979 Feb; 39(2 Pt 1):411-4. PubMed ID: 104789
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK, Garcia CT, Ashendel CL, Boutwell RK.
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [Abstract] [Full Text] [Related]

  • 10. Carcinogenicity and mutagenicity of the 3,4-dihydrodiols and other metabolites of 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives.
    Wislocki PG, Gadek KM, Chou MW, Yang SK, Lu AY.
    Cancer Res; 1980 Oct; 40(10):3661-4. PubMed ID: 6777036
    [No Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT, Wood AW, Chang RL, Yagi H, Sayer JM, Jerina DM, Conney AH.
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [Abstract] [Full Text] [Related]

  • 12. Analysis of highly polar DNA adducts formed in SENCAR mouse epidermis following topical application of dibenz[a,j]anthracene.
    Vulimiri SV, Baer-Dubowska W, Harvey RG, Zhang JT, DiGiovanni J.
    Chem Res Toxicol; 1999 Jan; 12(1):60-7. PubMed ID: 9894019
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the tumor-initiating activities of benzo(a)pyrene arene oxides and diol-epoxides.
    Slaga TJ, Bracken WM, Viaje A, Levin W, Yagi H, Jerina DM, Conney AH.
    Cancer Res; 1977 Nov; 37(11):4130-3. PubMed ID: 908047
    [Abstract] [Full Text] [Related]

  • 14. Dose-response studies on the ability of 7,12-dimethylbenz(alpha)anthracene and benz(alpha)anthracene to initiate skin tumors.
    Slaga TJ, Bowden GT, Scribner JD, Boutwell RK.
    J Natl Cancer Inst; 1974 Nov; 53(5):1337-40. PubMed ID: 4431053
    [No Abstract] [Full Text] [Related]

  • 15. Comparative tumor-initiating activity of methylated benzo(a)pyrene derivatives in mouse skin.
    Iyer RP, Lyga JW, Secrist JA, Daub GH, Slaga TJ.
    Cancer Res; 1980 Apr; 40(4):1073-6. PubMed ID: 7357537
    [Abstract] [Full Text] [Related]

  • 16. Exceptionally high tumor-initiating activity of benzo(c)phenanthrene bay-region diol-epoxides on mouse skin.
    Levin W, Wood AW, Chang RL, Ittah Y, Croisy-Delcey M, Yagi H, Jerina DM, Conney AH.
    Cancer Res; 1980 Nov; 40(11):3910-4. PubMed ID: 7471042
    [No Abstract] [Full Text] [Related]

  • 17. Metabolism and tumorigenicity of 7-, 8-, 9-, and 10-fluorobenzo(a)pyrenes.
    Buhler DR, Unlu F, Thakker DR, Slaga TJ, Newman MS, Levin W, Conney AH, Jerina DM.
    Cancer Res; 1982 Nov; 42(11):4779-83. PubMed ID: 6290047
    [Abstract] [Full Text] [Related]

  • 18. Correlation between formation of a specific hydrocarbon-deoxyribonucleoside adduct and tumor-initiating activity of 7,12-dimethylbenz(a)anthracene and its 9- and 10-monofluoroderivatives in mice.
    DiGiovanni J, Sawyer TW, Fisher EP.
    Cancer Res; 1986 Sep; 46(9):4336-41. PubMed ID: 3089589
    [Abstract] [Full Text] [Related]

  • 19. High tumorigenicity of the 3,4-dihydrodiol of 7-methylbenz[c]acridine on mouse skin and in newborn mice.
    Chang RL, Levin W, Wood AW, Shirai N, Ryan AJ, Duke CC, Jerina DM, Holder GM, Conney AH.
    Cancer Res; 1986 Sep; 46(9):4552-5. PubMed ID: 3731110
    [Abstract] [Full Text] [Related]

  • 20. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
    Scribner JD, Scribner NK, McKnight B, Mottet NK.
    Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.